Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Safety, Tolerability and Bioavailability of NN9925 in Healthy Male Subjects

NCT01087645 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01087645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01087645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Safety, Tolerability and Bioavailability of NN9925 in Healthy Male Subjects
Lead sponsor
Novo Nordisk A/S
Phase
Phase 1
Overall status
Completed
Start date
March 12, 2010
Completion date
September 16, 2010
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2, healthy